Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Abroad (travel likely)RecruitingPHASE4

Conditions

Neurodegenerative Diseases · Parkinson Disease · Parkinson Disease Psychosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Study coordinator (Levi Pettit, BA) · levi.f.pettit@vumc.org · 615-421-0569
Contact: Study coordinator (Katie Hay, MS) · katie.orourke@vumc.org · 6158757403

Study leads

Ciaran Considine, PhD
Principal Investigator
Vanderbilt University Medical Center
Richard Darby, MD
Principal Investigator
Vanderbilt University Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton

Parkinson Disease

Abroad (travel likely)Recruiting

Elkins Park, United States

Neurofeedback Rehabilitation With FES and VR for PD

Parkinson Disease

Abroad (travel likely)Recruiting

Schiedlberg, Austria

Light Therapy in Parkinson's Disease

Parkinson Disease · Sleep Disorder · Circadian Rhythm Disorders

Abroad (travel likely)Recruiting

Suzhou, China

Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)

Parkinson Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Ventura, United States